EMA clarifies: No Russian application for vaccine approval

The European Medicines Agency has received no application for a rolling review or a marketing authorization from the Russian vaccine candidate Sputnik V, according to EMA press release.

Photo: Rob Acket/EMA

The EU's health authority, the European Medicines Agency (EMA), has neither received an application for a rolling review, nor one for a marketing authorization for the Russian vaccine candidate Sputnik V.

The EMA informs as much on Wednesday in a clarification on its website following rumors that the vaccine candidate production team has applied for EU approval.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs